{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:09:12Z","timestamp":1792015752211,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.ejca.2006.09.005","type":"journal-article","created":{"date-parts":[[2006,11,4]],"date-time":"2006-11-04T07:14:20Z","timestamp":1162624460000},"page":"114-121","source":"Crossref","is-referenced-by-count":158,"title":["Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973)"],"prefix":"10.1016","volume":"43","author":[{"given":"Jos\u00e9","family":"Belderbos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon","family":"Uitterhoeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"van Zandwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huub","family":"Belderbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rodrigus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"van de Vaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"van Walree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Dussenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Bartelink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caro","family":"Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2006.09.005_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-8140(99)00093-6","article-title":"A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial","volume":"52","author":"Ball","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2006.09.005_bib2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0959-8049(01)00363-X","article-title":"The combined use of radiotherapy and chemotherapy in the treatment of solid tumours","volume":"38","author":"Bartelink","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2006.09.005_bib3","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1200\/JCO.2005.09.108","volume":"23","author":"Belani","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.09.005_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1200\/JCO.1999.17.1.4","article-title":"Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group","volume":"17","author":"Clamon","year":"1999","journal-title":"J Clin Oncol"},{"issue":"Suppl. 2","key":"10.1016\/j.ejca.2006.09.005_bib5","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0169-5002(02)00351-3","article-title":"Gemzar platinum combinations: phase III trials in non-small cell lung cancer","volume":"38","author":"Crino","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejca.2006.09.005_bib6","first-page":"621","article-title":"Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III nsclc: RTOG 9410","volume":"22","author":"Curran","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2006.09.005_bib7","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/88.17.1210","article-title":"Green MR. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial","volume":"88","author":"Dillman","year":"1996","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl. 2","key":"10.1016\/j.ejca.2006.09.005_bib8","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0169-5002(05)80172-2","volume":"49","author":"Douillard","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejca.2006.09.005_bib9","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1200\/JCO.2005.03.070","article-title":"Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d\u2019Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study","volume":"23","author":"Fournel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.09.005_bib10","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.09.005_bib11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(01)05965-7","article-title":"Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis","volume":"358","author":"Green","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2006.09.005_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/annonc\/mdh100","article-title":"Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study","volume":"15","author":"Groen","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2006.09.005_bib13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1200\/JCO.2005.07.015","article-title":"Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer: long-term results of a phase II study","volume":"23","author":"Jeremic","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.09.005_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.coc.0000145986.78542.44","article-title":"Five-year results of a phase II trial of hyperfractionated radiotherapy and concurrent daily cisplatin chemotherapy for stage III non-small-cell lung cancer","volume":"28","author":"Keene","year":"2005","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.09.005_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jnci\/83.6.417","article-title":"Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients","volume":"83","author":"Le Chevalier","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2006.09.005_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2004.10.014","article-title":"Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes","volume":"47","author":"Le Chevalier","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejca.2006.09.005_bib17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials","volume":"311","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2006.09.005_bib18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-0","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2006.09.005_bib19","first-page":"CD002140","article-title":"Concurrent chemoradiotherapy in non-small cell lung cancer","author":"Rowell","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejca.2006.09.005_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1378\/chest.117.2.358","article-title":"Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group","volume":"117","author":"Sause","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ejca.2006.09.005_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199202203260805","article-title":"Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer","volume":"326","author":"Schaake-Koning","year":"1992","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2006.09.005_bib22","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ijrobp.2005.01.003","article-title":"The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer","volume":"62","author":"Schild","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2006.09.005_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0360-3016(92)91014-E","article-title":"Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer","volume":"24","author":"Trovo","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2006.09.005_bib24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0959-8049(99)00315-9","article-title":"Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I\/II study. European Organization for Research and Treatment of Cancer","volume":"36","author":"Uitterhoeve","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2006.09.005_bib25","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1200\/JCO.2000.18.14.2658","article-title":"Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)","volume":"18","author":"van Zandwijk","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.09.005_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.lungcan.2004.03.004","article-title":"Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study","volume":"46","author":"Zatloukal","year":"2004","journal-title":"Lung Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804906008124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804906008124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T13:24:05Z","timestamp":1547213045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804906008124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0959804906008124"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2006.09.005","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}